David E Lewis

Title: David E Lewis: Innovator in Microbial Inhibition and Anticoagulant Composition

Introduction

David E Lewis is a notable inventor based in Eau Claire, WI (US). He holds a total of 9 patents that showcase his contributions to the fields of microbial inhibition and anticoagulant compositions. His innovative work has significant implications for various industries, particularly in health and safety.

Latest Patents

Among his latest patents, one focuses on quaternary ammonium salts as microbe inhibitors. This invention relates to the preparation of quaternary ammonium salts through a chloride ion-promoted reaction between a tertiary amine and an alcohol or polyol in a strong acid solution. These salts can be applied to substrates, such as paper, to impart anti-mold properties without the need for encapsulators or binders. Another significant patent is the synergistic anticoagulant composition, which enhances the effects of warfarin in mammalian subjects. This composition features a compound with a naphthohydroquinone ring system, which is similar to the reduced form of vitamin K.

Career Highlights

David E Lewis has worked with several organizations throughout his career. Notably, he has been associated with Mionix Corporation and Marshfield Clinic Health System, Inc. His work in these companies has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his inventions.

Collaborations

Throughout his career, David has collaborated with notable individuals such as Maurice Clarence Kemp and Robert Blaine Lalum. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

David E Lewis is a distinguished inventor whose work in microbial inhibition and anticoagulant compositions has made a significant impact. His innovative patents reflect his dedication to improving health and safety through scientific advancements.